Old drug, new hope: growth hormone shows promise for End-Stage liver disease
NCT ID NCT05253287
First seen Jan 04, 2026 · Last updated Apr 28, 2026 · Updated 21 times
Summary
This study tested whether giving growth hormone to people with advanced liver cirrhosis could improve their survival and quality of life. The trial included 96 adults with decompensated cirrhosis, a stage where the liver is failing and life expectancy is short. Researchers measured complications, nutrition, and liver function to see if the hormone could help the body fight the disease better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Postgraduate Institute of Medical education and Research
Chandigarh, Uttarakhand, 160012, India
Conditions
Explore the condition pages connected to this study.